South Korean medical aesthetics device maker Hironic has signed a three-year exclusive distribution agreement with UAE-based KMED Trading LLC for its premium skin treatment platform 'Silkro'. The deal grants KMED sole sales rights across the UAE, a rapidly growing hub for medical aesthetics in the Middle East, offering overseas buyers a new channel for advanced combination-technology devices.
Deal details
Hironic announced the exclusive distribution contract with KMED Trading LLC, a Dubai-headquartered medical aesthetics distributor with a network of aesthetic clinics across the UAE. The agreement covers a three-year term, renewable by mutual consent, and grants KMED exclusive sales rights for Silkro in the UAE market.
Product profile
Silkro is a multi-functional skin treatment platform combining RF microneedle (RM) and plasma (PS) technologies. It supports various handpiece configurations for skin tightening and aesthetic management, including RF bipolar, plasma, and RF vaginal treatment modes. The platform can be customized to meet different clinic treatment needs.
Market signal
A Hironic official stated, "The UAE is a key hub leading Middle Eastern medical aesthetics trends, with rapidly growing demand for non-invasive and minimally invasive skincare devices." The company plans to boost market share through close collaboration with KMED, including product training and academic seminars.
Sourcing context
Hironic has been rapidly expanding its global distribution network, recently signing partnerships in Poland, Lithuania, Thailand, Slovakia, the United States, and Hong Kong. This UAE deal further strengthens its presence in the Middle East, a region where premium aesthetic device demand is rising among clinics and distributors.
Source: Read the original report | Published: June 17, 2026